Contineum Therapeutics, Inc. — SCHEDULE 13G Filings
2 SCHEDULE 13G filings on record
This page lists all SCHEDULE 13G filings submitted to the SEC by Contineum Therapeutics, Inc. (CTNM), sorted by most recent first. Each row links to the full filing on EdgarLookup. Contineum Therapeutics, Inc. has filed 2 SCHEDULE 13G documents with the SEC since 2023. To view all SEC filings by Contineum Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-3
S-8
SC 13G
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0001193125-26-052863 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0001415889-25-020291 | Jul 25, 2025 | — |